-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Champions Oncology, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2013 to 2023.
- Champions Oncology, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending July 31, 2024 was 14M shares, a 3.97% increase year-over-year.
- Champions Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 13.5M shares, a 0.05% increase from 2022.
- Champions Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 13.5M shares, a 4.37% decline from 2021.
- Champions Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 14.2M shares, a 2.84% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)